Health
Medical Treatment & Drug Development
Pandemics & Infectious Diseases
Antimicrobials, Antibiotics & Drug Resistances
Biotech- and Nanotechnology
Ph.D
France
2012.09.30
Producing new antimicrobials and enhancing the current drugs polymorphism to fight drug resistance through a new metabolic engineering framework
Affordable, new antibiotics are needed and Cyrille Pauthenier hopes to engineer yeast cells to produce them for us. To avoid toxicity, the process will take place on the outside of the cell, making collection of the new drugs easy and harmless.
TAKING DRUG DESIGN INTO CELLS AND OUT AGAIN
To add or modify information on this page, please contact us at the following address: community.research@axa.com
Cyrille
PAUTHENIER
Institution
Université d'Evry-Val-d'Essonne
Country
France
Nationality
French
Related articles
Health
Chronic & Non Communicable Diseases
Medical Treatment & Drug Development
Chronic Pain & Musculoskeletal Disorders
Drug Delivery
Biotech- and Nanotechnology
AXA Project
France
Pain Pediatric & Elderly AXA Research Lab (PEARL)
Chronic pain is recognized as a major public health problem affecting patients in their daily activity, physical and mental health,... Read more
Celine
GRECO
